# Madison Avenue Partners, LP

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1801265. Source: https://holderbook.com/funds/1801265-madison-avenue-partners-lp/

- Reported value: $2.3B
- Positions: 25
- Weight of the ten largest: 77.1%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| GRAHAM HLDGS CO | [GHC](https://holderbook.com/stocks/GHC/) | $281.2M | 246,368 | 12.1% | 26 |
| INVITATION HOMES INC | [INVH](https://holderbook.com/stocks/INVH/) | $251.8M | 8,335,309 | 10.8% | 1 |
| MARKEL GROUP INC | [MKL](https://holderbook.com/stocks/MKL/) | $219.4M | 112,325 | 9.4% | 6 |
| COUPANG INC | [CPNG](https://holderbook.com/stocks/CPNG/) | $216.4M | 12,457,195 | 9.3% | 2 |
| MAGNUM ICE CREAM CO NV | [MICC](https://holderbook.com/stocks/MICC/) | $189.6M | 10,892,592 | 8.2% | 3 |
| THERAVANCE BIOPHARMA INC | [TBPH](https://holderbook.com/stocks/TBPH/) | $156.6M | 9,212,252 | 6.7% | 20 |
| SOLVENTUM CORP | [SOLV](https://holderbook.com/stocks/SOLV/) | $134.3M | 1,741,221 | 5.8% | 9 |
| STAAR SURGICAL CO | [STAA](https://holderbook.com/stocks/STAA/) | $119.8M | 4,175,748 | 5.2% | 2 |
| INDIVIOR PHARMACEUTICALS INC | [INDV](https://holderbook.com/stocks/INDV/) | $117.9M | 2,874,368 | 5.1% | 3 |
| LAKEFRONT BIOTHERAPEUTICS NV | [LKFT](https://holderbook.com/stocks/LKFT/) | $103.4M | 3,447,807 | 4.4% | 5 |
| GLOBUS MED INC | [GMED](https://holderbook.com/stocks/GMED/) | $73.9M | 935,216 | 3.2% | 5 |
| OCTAVE INTELLIGENCE PLC | [OCTLF](https://holderbook.com/stocks/OCTLF/) | $68.8M | 4,222,663 | 3.0% | 1 |
| BRITISH AMERN TOB PLC | [BTI](https://holderbook.com/stocks/BTI/) | $64.4M | 1,043,302 | 2.8% | 4 |
| STAGWELL INC | [STGW](https://holderbook.com/stocks/STGW/) | $59.5M | 8,014,322 | 2.6% | 20 |
| SANMINA CORP | [SANM](https://holderbook.com/stocks/SANM/) | $47.7M | 188,322 | 2.1% | 1 |
| PRIMORIS SVCS CORP | [PRIM](https://holderbook.com/stocks/PRIM/) | $45.8M | 462,058 | 2.0% | 1 |
| ARRAY DIGITAL INFRASTRUCTURE | [AD](https://holderbook.com/stocks/AD/) | $40.2M | 1,109,463 | 1.7% | 1 |
| APARTMENT INVT &amp; MGMT CO | [AIV](https://holderbook.com/stocks/AIV/) | $36.8M | 12,374,991 | 1.6% | 2 |
| SANDISK CORP | [SNDK](https://holderbook.com/stocks/SNDK/) | $22.1M | 9,698 | 0.9% | 5 |
| TURNING PT BRANDS INC | [TPB](https://holderbook.com/stocks/TPB/) | $21.0M | 247,823 | 0.9% | 3 |
| SINCLAIR INC | [SBGI](https://holderbook.com/stocks/SBGI/) | $19.7M | 1,383,470 | 0.8% | 3 |
| MAGNERA CORP | [MAGN](https://holderbook.com/stocks/MAGN/) | $15.3M | 1,302,066 | 0.7% | 7 |
| MILLROSE PPTYS INC | [MRP](https://holderbook.com/stocks/MRP/) | $9.0M | 298,461 | 0.4% | 1 |
| KEROS THERAPEUTICS INC | [KROS](https://holderbook.com/stocks/KROS/) | $6.7M | 626,583 | 0.3% | 5 |
| MONRO INC | [MNRO](https://holderbook.com/stocks/MNRO/) | $1.6M | 95,966 | 0.1% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | +57.1% | +14.8% | +42.3% | 100% |
| Q1 2026 | +21.6% | -4.6% | +26.3% | 100% |
| Q4 2025 | +27.3% | +2.4% | +24.9% | 100% |
| Q3 2025 | +29.3% | +7.8% | +21.4% | 95% |
| Q2 2025 | +2.5% | +10.5% | -8.0% | 99% |
| Q1 2025 | +2.4% | -4.6% | +6.9% | 92% |
| Q4 2024 | +0.4% | +2.1% | -1.7% | 100% |
| Q3 2024 | +17.8% | +5.4% | +12.4% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $2.3B | 25 |
| Q1 2026 | $2.3B | 27 |
| Q4 2025 | $2.3B | 23 |
| Q3 2025 | $1.7B | 20 |
| Q2 2025 | $1.5B | 26 |
| Q1 2025 | $1.2B | 22 |
| Q4 2024 | $944.4M | 15 |
| Q3 2024 | $1.1B | 25 |
| Q2 2024 | $791.6M | 20 |
| Q1 2024 | $619.9M | 18 |
| Q4 2023 | $708.3M | 19 |
| Q3 2023 | $704.7M | 20 |

